[271]
lymphoma in Taiwan Striking male predominance of mantle cell
From [jcp.bmjjournals.com] Last viewed: 07.09.2006
lymphoma
1581
Customized Cancer Medicine
All Treatments are Customized at the point of delivery
All Treatments Are Designed to Take advantage of Differences between Cancer Cells and Normal Cells
Some of these differences are Generic and some are more Specific to the Type of Cancer, the Subtype, or even to the Individual Person
Customized Cancer Medicine
Generic Treatments
Cancer Starts from One Cell in One Place
Surgery- Early Detection
Cancer Cells Divide Faster
Chemotherapy and Radiotherapy
Cancer Type Specific Treatments
Hormone Responsive
Prostate/Breast
Tissue Type
Thyroid
Receptors
Monoclonal Antibodies
Customized Cancer Medicine ...
[272]
062995 Treatment of Adult T-Cell Leukemia-Lymphoma
From [content.nejm.org] Last viewed: 07.09.2006
Neurological Signs due to Spinal Lymphoma in a Ferret
Jennifer M. Mateleska, DVM and Joerg Mayer, Dr. Med.vet., MSc.
Lymphoma is one of the most common neoplasias seen in ferrets and can
affect ferrets of all ages. The disease can involve numerous tissues, most often
including peripheral and visceral lymph nodes, liver, spleen, bone marrow, kidney,
lung, mediastinum, and intestine. Less often, the nervous system, stomach,
pancreas, adrenal glands, and skin are involved. Clinical signs of lymphoma in ferrets
are often vague and can mimic those seen in other diseases. Viral involvement has
been suggested, but there is no significant evidence of this to date.
Presentation
A six-year-old castrated male ferret named Fred presented to the Exotics
Service at Tufts University School of Veterinary Medicine with a three-day history of
lethargy and hind limb paresis. There was no known history of trauma ...
[273]
071599 Cystic Lymphoma of the Brain
From [content.nejm.org] Last viewed: 07.09.2006
Neurological Signs due to Spinal Lymphoma in a Ferret
Jennifer M. Mateleska, DVM and Joerg Mayer, Dr. Med.vet., MSc.
Lymphoma is one of the most common neoplasias seen in ferrets and can
affect ferrets of all ages. The disease can involve numerous tissues, most often
including peripheral and visceral lymph nodes, liver, spleen, bone marrow, kidney,
lung, mediastinum, and intestine. Less often, the nervous system, stomach,
pancreas, adrenal glands, and skin are involved. Clinical signs of lymphoma in ferrets
are often vague and can mimic those seen in other diseases. Viral involvement has
been suggested, but there is no significant evidence of this to date.
Presentation
A six-year-old castrated male ferret named Fred presented to the Exotics
Service at Tufts University School of Veterinary Medicine with a three-day history of
lethargy and hind limb paresis. There was no known history of trauma ...
[274]
Angiocentric T-Cell Intestinal Lymphoma with Epstein-Barr Virus 5 ...
From [ijs.sagepub.com] Last viewed: 07.09.2006
Neurological Signs due to Spinal Lymphoma in a Ferret
Jennifer M. Mateleska, DVM and Joerg Mayer, Dr. Med.vet., MSc.
Lymphoma is one of the most common neoplasias seen in ferrets and can
affect ferrets of all ages. The disease can involve numerous tissues, most often
including peripheral and visceral lymph nodes, liver, spleen, bone marrow, kidney,
lung, mediastinum, and intestine. Less often, the nervous system, stomach,
pancreas, adrenal glands, and skin are involved. Clinical signs of lymphoma in ferrets
are often vague and can mimic those seen in other diseases. Viral involvement has
been suggested, but there is no significant evidence of this to date.
Presentation
A six-year-old castrated male ferret named Fred presented to the Exotics
Service at Tufts University School of Veterinary Medicine with a three-day history of
lethargy and hind limb paresis. There was no known history of trauma ...
[275]
Leukemia, Lymphoma, and Myeloma
[27,0 KB]
From [www.odh.ohio.gov] Last viewed: 07.09.2006
Leukemia, Lymphoma , and Myeloma
Leukemia, lymphoma , and myeloma are cancers that originate in the bone
marrow (in the case of leukemia and myeloma) or in lymphatic tissues (in
the case of lymphoma ).
Leukemia, lymphoma , and myeloma are considered to be related cancers
because they involve the uncontrolled growth of cells with similar functions
and origins. The diseases result from an acquired (not inherited) genetic
injury to the DNA of a single cell, which becomes abnormal (malignant) and
multiplies continuously. The accumulation of malignant cells interferes with
the body's production of healthy blood cells and makes the body unable to
protect itself against infections.
Leukemia - Leukemia is a malignant disease (cancer) that originates in a cell
in the marrow.
Non-Hodgkin Lymphoma - Lymphoma is a general term for a group of
cancers that originate in the lymphatic system. ...
[276]
#4054 Intravascular Lymphoma
From [www.jaaha.org] Last viewed: 07.09.2006
55
International Pediatrics/Vol. 18/No. 1/2003
Burkitt’s Lymphoma
Clinical Article
The Endoscopic and Computed Tomographic Appearance of
Burkitt’s Lymphoma of the Stomach with Follow-up Studies
Ali Mirza Onder, MD; Jesse Reeves-Garica, MD
Abstract
This is a report of a previously healthy 17-year-old male who was
initially presented with abdominal pain, vomiting, dyspepsia, gener-
alized malaise, and weight loss for 3 months duration. As per history
on admission, he did not benefit from two courses of Helicobacter
pylori eradication treatment with antibiotics and proton-pump inhibi-
tors. His initial work-up in another facility included an upper gas-
trointestinal (GI) series which was negative. During the upper GI
endoscopy, a large yellow-white ulcer crater was detected covering
the lesser curvature of the stomach with a large blue hard mass
central to the crater. ...
[277]
Extensive Wall Thickening in Intestinal Burkitt Lymphoma
From [www.jultrasoundmed.org] Last viewed: 07.09.2006
55
International Pediatrics/Vol. 18/No. 1/2003
Burkitt’s Lymphoma
Clinical Article
The Endoscopic and Computed Tomographic Appearance of
Burkitt’s Lymphoma of the Stomach with Follow-up Studies
Ali Mirza Onder, MD; Jesse Reeves-Garica, MD
Abstract
This is a report of a previously healthy 17-year-old male who was
initially presented with abdominal pain, vomiting, dyspepsia, gener-
alized malaise, and weight loss for 3 months duration. As per history
on admission, he did not benefit from two courses of Helicobacter
pylori eradication treatment with antibiotics and proton-pump inhibi-
tors. His initial work-up in another facility included an upper gas-
trointestinal (GI) series which was negative. During the upper GI
endoscopy, a large yellow-white ulcer crater was detected covering
the lesser curvature of the stomach with a large blue hard mass
central to the crater. ...
[278]
Uterine Lymphoma:
From [www.jultrasoundmed.org] Last viewed: 07.09.2006
55
International Pediatrics/Vol. 18/No. 1/2003
Burkitt’s Lymphoma
Clinical Article
The Endoscopic and Computed Tomographic Appearance of
Burkitt’s Lymphoma of the Stomach with Follow-up Studies
Ali Mirza Onder, MD; Jesse Reeves-Garica, MD
Abstract
This is a report of a previously healthy 17-year-old male who was
initially presented with abdominal pain, vomiting, dyspepsia, gener-
alized malaise, and weight loss for 3 months duration. As per history
on admission, he did not benefit from two courses of Helicobacter
pylori eradication treatment with antibiotics and proton-pump inhibi-
tors. His initial work-up in another facility included an upper gas-
trointestinal (GI) series which was negative. During the upper GI
endoscopy, a large yellow-white ulcer crater was detected covering
the lesser curvature of the stomach with a large blue hard mass
central to the crater. ...
[279]
Editorial Anaplastic large cell lymphoma: what’s in a name?
[86,2 KB]
From [jcp.bmjjournals.com] Last viewed: 07.09.2006
lymphoma
1581
Customized Cancer Medicine
All Treatments are Customized at the point of delivery
All Treatments Are Designed to Take advantage of Differences between Cancer Cells and Normal Cells
Some of these differences are Generic and some are more Specific to the Type of Cancer, the Subtype, or even to the Individual Person
Customized Cancer Medicine
Generic Treatments
Cancer Starts from One Cell in One Place
Surgery- Early Detection
Cancer Cells Divide Faster
Chemotherapy and Radiotherapy
Cancer Type Specific Treatments
Hormone Responsive
Prostate/Breast
Tissue Type
Thyroid
Receptors
Monoclonal Antibodies
Customized Cancer Medicine ...
[280]
Short report Primary peripheral T cell lymphoma of the endometrium
[157,6 KB]
From [jcp.bmjjournals.com] Last viewed: 07.09.2006
lymphoma
1581
Customized Cancer Medicine
All Treatments are Customized at the point of delivery
All Treatments Are Designed to Take advantage of Differences between Cancer Cells and Normal Cells
Some of these differences are Generic and some are more Specific to the Type of Cancer, the Subtype, or even to the Individual Person
Customized Cancer Medicine
Generic Treatments
Cancer Starts from One Cell in One Place
Surgery- Early Detection
Cancer Cells Divide Faster
Chemotherapy and Radiotherapy
Cancer Type Specific Treatments
Hormone Responsive
Prostate/Breast
Tissue Type
Thyroid
Receptors
Monoclonal Antibodies
Customized Cancer Medicine ...
[281]
Langerhans cell histiocytosis in sequential discordant lymphoma
[351,2 KB]
From [jcp.bmjjournals.com] Last viewed: 07.09.2006
lymphoma
1581
Customized Cancer Medicine
All Treatments are Customized at the point of delivery
All Treatments Are Designed to Take advantage of Differences between Cancer Cells and Normal Cells
Some of these differences are Generic and some are more Specific to the Type of Cancer, the Subtype, or even to the Individual Person
Customized Cancer Medicine
Generic Treatments
Cancer Starts from One Cell in One Place
Surgery- Early Detection
Cancer Cells Divide Faster
Chemotherapy and Radiotherapy
Cancer Type Specific Treatments
Hormone Responsive
Prostate/Breast
Tissue Type
Thyroid
Receptors
Monoclonal Antibodies
Customized Cancer Medicine ...
[282]
Angiotropic lymphoma occurring in a lacrimal sac oncocytoma
[119,6 KB]
From [jcp.bmjjournals.com] Last viewed: 07.09.2006
lymphoma
1581
Customized Cancer Medicine
All Treatments are Customized at the point of delivery
All Treatments Are Designed to Take advantage of Differences between Cancer Cells and Normal Cells
Some of these differences are Generic and some are more Specific to the Type of Cancer, the Subtype, or even to the Individual Person
Customized Cancer Medicine
Generic Treatments
Cancer Starts from One Cell in One Place
Surgery- Early Detection
Cancer Cells Divide Faster
Chemotherapy and Radiotherapy
Cancer Type Specific Treatments
Hormone Responsive
Prostate/Breast
Tissue Type
Thyroid
Receptors
Monoclonal Antibodies
Customized Cancer Medicine ...
[283]
Short reports Histiocytic lymphoma presenting as a testicular ...
[142,1 KB]
From [jcp.bmjjournals.com] Last viewed: 07.09.2006
lymphoma
1581
Customized Cancer Medicine
All Treatments are Customized at the point of delivery
All Treatments Are Designed to Take advantage of Differences between Cancer Cells and Normal Cells
Some of these differences are Generic and some are more Specific to the Type of Cancer, the Subtype, or even to the Individual Person
Customized Cancer Medicine
Generic Treatments
Cancer Starts from One Cell in One Place
Surgery- Early Detection
Cancer Cells Divide Faster
Chemotherapy and Radiotherapy
Cancer Type Specific Treatments
Hormone Responsive
Prostate/Breast
Tissue Type
Thyroid
Receptors
Monoclonal Antibodies
Customized Cancer Medicine ...
[284]
Short reports Soft tissue malignant lymphoma at sites of previous ...
[303,1 KB]
From [jcp.bmjjournals.com] Last viewed: 07.09.2006
lymphoma
1581
Customized Cancer Medicine
All Treatments are Customized at the point of delivery
All Treatments Are Designed to Take advantage of Differences between Cancer Cells and Normal Cells
Some of these differences are Generic and some are more Specific to the Type of Cancer, the Subtype, or even to the Individual Person
Customized Cancer Medicine
Generic Treatments
Cancer Starts from One Cell in One Place
Surgery- Early Detection
Cancer Cells Divide Faster
Chemotherapy and Radiotherapy
Cancer Type Specific Treatments
Hormone Responsive
Prostate/Breast
Tissue Type
Thyroid
Receptors
Monoclonal Antibodies
Customized Cancer Medicine ...
[285]
Variation in gene expression patterns in follicular lymphoma and ...
[333,1 KB]
From [www.pnas.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[286]
Rapid production of specific vaccines for lymphoma by expression ...
[142,1 KB]
From [www.pnas.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[287]
Exclusive expression of Epstein-Barr virus nuclear antigen 1 in ...
[1380,4 KB]
From [www.pnas.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[288]
Lymphoma development in mice and humans: Diversity of initiation ...
[1153,9 KB]
From [www.pnas.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[289]
Natural antibodies the structural protein of the T-cell leukemia ...
[966,8 KB]
From [www.pnas.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[290]
Induction of lymphoma in athymic mice: A model for study the human ...
[1299,6 KB]
From [www.pnas.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[291]
Leukaemia, lymphoma, and multiple myeloma in seamen on tankers
[163,4 KB]
From [oem.bmjjournals.com] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[292]
Latest lymphoma classificationisskindeep
[113,7 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[293]
MolecularmonitoringofEBV-positive lymphoma
[179,5 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[294]
Gene expression profiling of follicular lymphoma and normal ...
[339,4 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[295]
Autologous transplantation for newly diagnosed follicular lymphoma ...
[741,4 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[296]
HIV-associated lymphoma: promising new results, but with toxicity
[531,5 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[297]
Rituximab and poor-risk follicular lymphoma
[796,8 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[298]
Holes in SOCS in primary mediastinal large B-cell lymphoma
[623,8 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[299]
Death of follicular lymphoma cells—the long and the short of it
[58,8 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...
[300]
Platelet message and microarrays Cytologic subtypes of grade 3 ...
[24,6 KB]
From [www.bloodjournal.org] Last viewed: 07.09.2006
North American Educational Forum on Lymphoma
November 2004, San Francisco, CA
Cancer Clinical Trials: An Overview
Patty Delaney, U.S. Food and Drug Administration
This is a transcript of an audio recording from the North American Educational Forum on Lymphoma ,
provided as a free service to the public. A professional medical transcription service produced the
transcript. LRF and the speakers have not edited the content for accuracy or omissions of information.
Patients are encouraged to talk to their physicians for complete information on how their disease should
be diagnosed, treated, and followed. LRF’s educational materials are not intended to take the place of
medical care or advice from your doctor. Webcasts (audio and slides) are archived at lymphoma .org.
Delaney:
Patty Delaney, Food and Drug Administration
F:
Female speaker
M:
Male speaker
M:
[UNRELATED ...